Gene therapy: How Veristat cut trial database costs by 30%
The gene therapy market is predicted to experience rapid growth over the coming years. But with that growth will come many complexities…
The gene therapy market is predicted to experience rapid growth over the coming years. But with that growth will come many complexities…
SOTIO Biotech has signed a research and licensing agreement with China-based Biocytogen to develop multiple bispecific antibody-drug conjugate (ADC) candidates…
This issue is driven by several factors, including the high cost of proprietary medications, the increasing use of the internet…
Asthma is a chronic immunological pulmonary disorder characterized by restriction of the airways, resulting in recurrent episodes of coughing, wheezing,…
The Asia Pacific (APAC) region is leading the charge for adoptive cell therapy studies, says Scotty Chung-Siu, a managing analyst…
Anti-obesity drugs will be the most impactful trend of 2024, followed by personalised and precision medicine, immuno-oncology (IO) drug development,…
The uptake of decentralized clinical trials (DCTs) solutions was greatly accelerated by the COVID-19 pandemic, with lockdowns necessitating that research…
US-based Rakuten Medical has announced positive interim data from the Phase Ib/II trial of its photoimmunotherapy, ASP-1929, in combination with…
UK-based Pheon Therapeutics has raised $120m in a Series B round to fund the clinical trials for its oncology pipeline…
Commit Biologics has emerged from stealth with €16m ($17.2m) in seed money to develop antibody therapies to treat cancer and…